{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:18Z","timestamp":1786984278281,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T00:00:00Z","timestamp":1528243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/M016560\/1"],"award-info":[{"award-number":["MR\/M016560\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Cambridge Comprehensive Biomedical Research Centre"},{"DOI":"10.13039\/501100000762","name":"Imperial College Healthcare NHS Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000762","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Research Council","award":["G510364"],"award-info":[{"award-number":["G510364"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ahj.2018.05.006","type":"journal-article","created":{"date-parts":[[2018,5,20]],"date-time":"2018-05-20T10:11:41Z","timestamp":1526811101000},"page":"102-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program\u2014AIM-HY INFORM trial"],"prefix":"10.1016","volume":"204","author":[{"given":"Omar","family":"Mukhtar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Cheriyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Cockcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Coulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indranil","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Faconti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Glover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Heagerty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teck K.","family":"Khong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian P.","family":"Mander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mellone N.","family":"Marchong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Una","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel M.","family":"McEniery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandosh","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Sever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian I.","family":"Shiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Wych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil J.","family":"Chowienczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian B.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10060","key":"10.1016\/j.ahj.2018.05.006_bb0005","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/S0140-6736(16)31134-5","article-title":"A call to action and a life-course strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension","volume":"388","author":"Olsen","year":"2016","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ahj.2018.05.006_bb0010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.jhh.1000516","article-title":"Ethnicity and cardiovascular risk: variations in people of African ancestry and South Asian origin","volume":"11","author":"Cappuccio","year":"1997","journal-title":"J Hum Hypertens"},{"issue":"5","key":"10.1016\/j.ahj.2018.05.006_bb0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/archinte.163.5.525","article-title":"Management of high blood pressure in african americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks","volume":"163","author":"Douglas","year":"2003","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.ahj.2018.05.006_bb0020","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1097\/01.hjh.0000186835.63996.d4","article-title":"Prevalence, awareness, treatment, and control of hypertension among black Surinamese, South Asian Surinamese and white Dutch in Amsterdam, the Netherlands: the SUNSET study","volume":"23","author":"Agyemang","year":"2005","journal-title":"J Hypertens"},{"issue":"28","key":"10.1016\/j.ahj.2018.05.006_bb0025","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ahj.2018.05.006_bb0030","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2018.05.006_bb0035","series-title":"Clinical guideline: 127","article-title":"Hypertension: clinical management of primary hypertension in adults (update)","author":"National Institute for Health and Clinical Excellence","year":"2011"},{"key":"10.1016\/j.ahj.2018.05.006_bb0040","series-title":"Population characteristics research tables","author":"Office for National Statistics","year":"2017"},{"issue":"4","key":"10.1016\/j.ahj.2018.05.006_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062005","article-title":"Assessment of the relationship between self-declared ethnicity, mitochondrial haplogroups and genomic ancestry in Brazilian individuals","volume":"8","author":"Cardena","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ahj.2018.05.006_bb0050","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/jmg.2010.078212","article-title":"Ancestry informative markers for fine-scale individual assignment to worldwide populations","volume":"47","author":"Paschou","year":"2010","journal-title":"J Med Genet"},{"issue":"3","key":"10.1016\/j.ahj.2018.05.006_bb0055","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/ajcn\/82.3.497","article-title":"Metabolomics in human nutrition: Opportunities and challenges","volume":"82","author":"Gibney","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"10.1016\/j.ahj.2018.05.006_bb0060","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.tifs.2008.03.003","article-title":"Metabolomics: applications to food science and nutrition research","volume":"19","author":"Wishart","year":"2008","journal-title":"Trends Food Sci Technol"},{"issue":"3","key":"10.1016\/j.ahj.2018.05.006_bb0065","first-page":"149","article-title":"Experimental designs balanced for the estimation of residual effect of treatments","volume":"2","author":"Williams","year":"1949","journal-title":"Aust J Sci Res"},{"issue":"3","key":"10.1016\/j.ahj.2018.05.006_bb0070","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/ng.3768","article-title":"Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk","volume":"49","author":"Warren","year":"2017","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.ahj.2018.05.006_bb0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/HYPERTENSIONAHA.116.08267","article-title":"Genome-wide and gene-based meta-analyses identify novel loci influencing blood pressure response to hydrochlorothiazide","volume":"69","author":"Salvi","year":"2017","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.ahj.2018.05.006_bb0080","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/hr.2016.164","article-title":"Metabolic phenotyping for discovery of urinary biomarkers of diet, xenobiotics and blood pressure in the INTERMAP Study: an overview","volume":"40","author":"Chan","year":"2017","journal-title":"Hypertens Res"},{"issue":"5","key":"10.1016\/j.ahj.2018.05.006_bb0085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10654-014-9910-7","article-title":"Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism","volume":"29","author":"Altmaier","year":"2014","journal-title":"Eur J Epidemiol"},{"issue":"13","key":"10.1016\/j.ahj.2018.05.006_bb0090","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1001\/jama.293.13.1595","article-title":"Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril","volume":"293","author":"Wright","year":"2005","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.ahj.2018.05.006_bb0095","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJMsa012979","article-title":"Contribution of major diseases to disparities in mortality","volume":"347","author":"Wong","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ahj.2018.05.006_bb0100","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/01.HYP.25.3.305","article-title":"Prevalence of hypertension in the US adult population: results from the third National Health and Nutrition Examination Survey. 1988-1991","volume":"25","author":"Burt","year":"1995","journal-title":"Hypertens"},{"issue":"16","key":"10.1016\/j.ahj.2018.05.006_bb0105","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1161\/CIRCULATIONAHA.110.005645","article-title":"Trends in mortality from all causes and cardiovascular disease among hypertensive and nonhypertensive adults in the United States","volume":"123","author":"Ford","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ahj.2018.05.006_bb0110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.290.2.199","article-title":"Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1998-2000","volume":"290","author":"Hajjar","year":"2003","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ahj.2018.05.006_bb0115","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/hrt.78.6.555","article-title":"Prevalence, detection and management of cardiovascular risk factors in different ethnic groups in south London","volume":"78","author":"Cappuccio","year":"1997","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.ahj.2018.05.006_bb0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0021-9150(98)00239-1","article-title":"Differences in biological risk factors for cardiovascular disease between three ethnic groups in the Whitehall II study","volume":"142","author":"Whitty","year":"1999","journal-title":"Atherosclerosis"},{"issue":"8738","key":"10.1016\/j.ahj.2018.05.006_bb0125","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0140-6736(91)91164-P","article-title":"Relationship of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians","volume":"337","author":"McKeigue","year":"1991","journal-title":"Lancet"},{"issue":"7204","key":"10.1016\/j.ahj.2018.05.006_bb0130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/bmj.319.7204.215","article-title":"Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study","volume":"319","author":"Bhopal","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2018.05.006_bb0135","series-title":"Health survey for England\u2014the health of minority ethnic groups \u201899 London","first-page":"175","article-title":"Blood pressure. Chapter 7","author":"Karlsen","year":"2001"},{"issue":"4","key":"10.1016\/j.ahj.2018.05.006_bb0140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/jdi.12166","article-title":"Association of hypertension status and cardiovascular risks with sympathovagal imbalance in first degree relatives of type 2 diabetics","volume":"5","author":"Pal","year":"2014","journal-title":"J Diabetes Investig"},{"issue":"5","key":"10.1016\/j.ahj.2018.05.006_bb0145","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.CIR.38.5.965","article-title":"Metabolic studies on hypertensive patients with suppressed plasma renin activity not due to hyperaldosteronism","volume":"38","author":"Helmer","year":"1968","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ahj.2018.05.006_bb0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0021-9681(80)90032-6","article-title":"Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity","volume":"33","author":"Grim","year":"1980","journal-title":"J Chronic Dis"},{"issue":"4","key":"10.1016\/j.ahj.2018.05.006_bb0155","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/HYPERTENSIONAHA.108.121665","article-title":"Whites excrete a water load more rapidly than Blacks","volume":"53","author":"Weder","year":"2009","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ahj.2018.05.006_bb0160","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1161\/HYPERTENSIONAHA.113.02989","article-title":"Racial differences in sensitivity of blood pressure to aldosterone","volume":"63","author":"Tu","year":"2014","journal-title":"Hypertension"},{"issue":"9113","key":"10.1016\/j.ahj.2018.05.006_bb0165","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(97)07306-6","article-title":"Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London","volume":"351","author":"Baker","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ahj.2018.05.006_bb0170","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ahj.2008.11.018","article-title":"Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study","volume":"157","author":"Johnson","year":"2009","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.ahj.2018.05.006_bb0175","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0002-9343(73)90128-9","article-title":"Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles","volume":"55","author":"Laragh","year":"1973","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.ahj.2018.05.006_bb0180","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0895-7061(01)01280-8","article-title":"Laragh's lessons in pathophysiology and clinical pearls for treating hypertension","volume":"14","author":"Laragh","year":"2001","journal-title":"Am J Hypertens"},{"issue":"5","key":"10.1016\/j.ahj.2018.05.006_bb0185","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0895-7061(99)00005-9","article-title":"Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects","volume":"12","author":"Blumenfeld","year":"1999","journal-title":"Am J Hypertens"},{"issue":"4","key":"10.1016\/j.ahj.2018.05.006_bb0190","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/08037050500230227","article-title":"Angiotensin receptor blockers: therapeutic targets and cardiovascular protection","volume":"14","author":"Ruilope","year":"2005","journal-title":"Blood Press"},{"issue":"1","key":"10.1016\/j.ahj.2018.05.006_bb0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.HYP.0000022570.02119.75","article-title":"Amiloride, a specific drug for hypertension in black people with T594M variant?","volume":"40","author":"Baker","year":"2002","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.ahj.2018.05.006_bb0200","first-page":"635","article-title":"Efficacy of calcium channel blockers on major cardiovascular outcomes for the treatment of hypertension in Asian populations: a meta-analysis","volume":"33","author":"Tran","year":"2017","journal-title":"Can J Cardiol"},{"issue":"5","key":"10.1016\/j.ahj.2018.05.006_bb0205","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1370\/afm.708","article-title":"Race and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: a systematic review","volume":"5","author":"Park","year":"2007","journal-title":"Ann Fam Med"},{"issue":"23","key":"10.1016\/j.ahj.2018.05.006_bb0210","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","author":"ALLHAT Officers and Coordinators","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ahj.2018.05.006_bb0215","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0735-1097(98)00423-9","article-title":"Rationale and design of the International Verapamil SR\/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension","volume":"32","author":"Pepine","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"9227","key":"10.1016\/j.ahj.2018.05.006_bb0220","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(00)02526-5","article-title":"Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study","volume":"356","author":"Hansson","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ahj.2018.05.006_bb0225","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.amjhyper.2006.09.006","article-title":"Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study)","volume":"20","author":"Hiltunen","year":"2007","journal-title":"Am J Hypertens"},{"issue":"3","key":"10.1016\/j.ahj.2018.05.006_bb0230","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1523-1755.2002.00200.x","article-title":"Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension","volume":"61","author":"Chapman","year":"2002","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.ahj.2018.05.006_bb0235","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/sj.tpj.6500113","article-title":"Pharmacogenetic approaches to hypertension therapy: design and rationale for the Genetics of Hypertension Associated Treatment (GenHAT) study","volume":"2","author":"Arnett","year":"2002","journal-title":"Pharmacogenomics J"},{"issue":"13","key":"10.1016\/j.ahj.2018.05.006_bb0240","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.107.704023","article-title":"Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics","volume":"118","author":"Johnson","year":"2008","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ahj.2018.05.006_bb0245","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7326\/0003-4819-141-8-200410190-00009","article-title":"Systematic review: antihypertensive drug therapy in black patients","volume":"141","author":"Brewster","year":"2004","journal-title":"Ann Intern Med"},{"issue":"21","key":"10.1016\/j.ahj.2018.05.006_bb0250","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"African American Study of Kidney Disease and Hypertension (AASK) Study Group. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial","volume":"285","author":"Agodoa","year":"2001","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ahj.2018.05.006_bb0255","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/ajh.2010.105","article-title":"Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial","volume":"23","author":"Gupta","year":"2010","journal-title":"Am J Hypertens"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287031830156X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287031830156X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:01:32Z","timestamp":1757570492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287031830156X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":51,"alternative-id":["S000287031830156X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2018.05.006","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program\u2014AIM-HY INFORM trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2018.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}